Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection
about
Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in ChinaAntiviral drug resistance as an adaptive processDeconvoluting the composition of low-frequency hepatitis C viral quasispecies: comparison of genotypes and NS3 resistance-associated variants between HCV/HIV coinfected hemophiliacs and HCV monoinfected patients in Japan.Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations.NS3 Resistance-Associated Variants (RAVs) in Patients Infected with HCV Genotype 1a in SpainPrevalence of HCV NS3 pre-treatment resistance associated amino acid variants within a Scottish cohort.CD4+ T-cell recovery with suppressive ART-induced rapid sequence evolution in hepatitis C virus envelope but not NS3.Characterization of HCV NS3 Protease Variants in HCV/HIV-Coinfected Patients by Ultra-Deep Sequence Analysis: Relationship with Hepatic Fibrosis.Similarities between Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Genetic and Phenotypic Protease Quasispecies Diversity.Naturally occurring hepatitis C virus protease inhibitors resistance-associated mutations among chronic hepatitis C genotype 1b patients with or without HIV co-infection.Development and Validation of Two Screening Assays for the Hepatitis C Virus NS3 Q80K Polymorphism Associated with Reduced Response to Combination Treatment Regimens Containing SimeprevirEffect of HIV/HCV Co-Infection on the Protease Evolution of HIV-1B: A Pilot Study in a Pediatric Population.Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection.Consequence of HIV and HCV co-infection on host immune response, persistence and current treatment options.
P2860
Q28552134-C1B9DE80-DC6F-4558-A19A-A7610B9FABADQ33878407-F1BDDD32-1896-450C-A255-B12DC7A09495Q35154587-450BA565-11A5-415E-9750-D7A88E121D11Q35914387-75837BE0-DAE4-456F-B70B-66C285345E88Q36148440-1CCBABD8-D4A8-40F2-BBE6-F360AD621D27Q36506480-2A906214-EB90-4926-9F30-76BFB7B9D365Q36619647-50A5D929-C894-4EE1-9DAB-05AD12C7F8FAQ40451354-C0A5E63B-1B4E-4661-9B82-C0D22429B645Q40732189-7A3BCEB7-DED6-4E56-9571-D30034DB3BB3Q41007229-AC73980B-3E81-49DE-B453-9872FC706006Q41127462-F725B9F6-ED25-43C0-9B64-E67FE4D7711BQ49363062-23B03539-5B4C-4D3C-878B-2B128FF51C8AQ49911983-36198437-4E67-4E4A-8D61-0EFB926722F0Q54243856-FC77ABFA-8D9D-4758-843D-A7F079B3C02E
P2860
Hepatitis C Virus (HCV) NS3 sequence diversity and antiviral resistance-associated variant frequency in HCV/HIV coinfection
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Hepatitis C Virus (HCV) NS3 se ...... equency in HCV/HIV coinfection
@ast
Hepatitis C Virus (HCV) NS3 se ...... equency in HCV/HIV coinfection
@en
type
label
Hepatitis C Virus (HCV) NS3 se ...... equency in HCV/HIV coinfection
@ast
Hepatitis C Virus (HCV) NS3 se ...... equency in HCV/HIV coinfection
@en
prefLabel
Hepatitis C Virus (HCV) NS3 se ...... equency in HCV/HIV coinfection
@ast
Hepatitis C Virus (HCV) NS3 se ...... equency in HCV/HIV coinfection
@en
P2093
P2860
P356
P1476
Hepatitis C Virus (HCV) NS3 se ...... equency in HCV/HIV coinfection
@en
P2093
Cassandra B Jabara
Corbin D Jones
Katie R Mollan
Michael G Hudgens
Michael W Fried
Prema Menezes
Sara E Williford
Stanley M Lemon
P2860
P304
P356
10.1128/AAC.03466-14
P407
P577
2014-08-04T00:00:00Z